InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,184.40
(
1.19%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.19
(
-1.27%
)
Bitcoin
61,747.49
(
2.46%
)

Replies to post #34807 on Applied DNA Sciences Inc (APDN)

Replies to #34807 on Applied DNA Sciences Inc (APDN)

mcsharkey

11/24/14 11:22 PM

#34808 RE: Pasta #34807

Yeah Pasta:

DLA is small potatoes. We need pharma and we need the hand held scanner to make it more practical

Agreeing with you. Noted in the S1 and prospectus, vaguely. But it's there a couple of times. This is from page 31 of the Halloween joke, shit, mean Prospectus:

We expect capital expenditures to be less than $400,000 in fiscal 2014. Our primary investments will be in laboratory equipment to support prototyping, manufacturing, our authentication services, and outside services for our detector and reader development. Substantially all of the real property used in our business is leased under operating lease agreements.

Reader being funded through the MDA grant. Protyping, manufacturing and authentication services funded (partially or wholly) by the Secretary of Defense grant through the DLA.

The agencies are improving our product by their demands. Nuther gamble I'm taking is Stonybrook will be successful.

AND, we'll see by June's DLA's Five FSG manufacturers symposium whether I got a chance of ever retiring.

Pleasant Dreams
Mike

apdn1mill

11/25/14 8:04 AM

#34814 RE: Pasta #34807

How can we expect revenues will go up even if APDN gets contracts with pharma companies. They still charge same pennies per marking.
Still it will be minimum 3 years to enter into pharma sector.just my opinion. So share price will be stagnant until then if they don't make much revenue from DLA